focus -WSS

focus

author：fashion 2025-09-30 17:46:10 - browse：8811

Is no one safe from the FTC? Has Pfizer bottomed out? And is biotech finally back?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we delve into the fallout over the FTC’s move to block what looked like a humdrum biotech deal between Sanofi and Maze Therapeutics, a surprising twist that leaves an unanswered question. We also discuss the latest news in the life sciences, including Pfizer’s downbeat future, Vertex Pharmaceuticals’ next big thing, and a newly minted biotech VC with a very famous name.

For more on what we cover, here’s the FTC news; here’s more from Maze Therapeutics; here’s the Pfizer news; here’s the latest on Vertex; here’s the story behind its pain drug; here’s the Reed Jobs profile; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： How state and local governments are sidelining science

WSS

Brain 'hot spot' may explain why African Americans feel greater pain

Doctor appointment wait times are getting worse

Van's Gluten Free Original Waffles recalled for possible wheat allergen

PhRMA sues HHS over Medicare drug price negotiation

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

White House drug czar issues call for 'recovery

hotspot

focus

knowledge

Continuity nursing helped my family in our darkest PICU moments

Listen: PBM conflicts, RSV vaccines, & the future of flu season

Anesthesiologist group: stop taking Ozempic before surgery

Listen: Biogen's messy board & Laronde's data problem

Apple is now the first public company to be valued at $3 trillion

CVS, Rite Aid closures threaten to worsen pharmacy deserts

At least 13 dead in Texas as scorching temps continue

4th of July breaks record for highest global temperature ever measured

New air purifier tech could be key to improving indoor air quality

Did the public have the right to know Arthur Ashe had AIDS?

hotspot

Ventyx halts psoriasis drug development after lackluster trial results

PhRMA sues HHS over Medicare drug price negotiation

What health policies could hitch a ride on a spending bill?

RaDonda Vaught case: a double standard for nurses, physicians

UnitedHealth sued over use of algorithm in Medicare Advantage plans

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

Wikipedia

explore

hotspot

hotspot